Hoomanely’s building a smart feeding bowl and an AI platform to help owners spot when their pup is sick
Palo Alto startup Hoomanely has launched EverBowl, a sensor-equipped dog feeding station paired with an AI platform intended to flag early signs of illness. By tracking changes in eating, drinking, chewing, swallowing, facial temperature and oral movement, it aims to give owners and veterinarians longer-term health information before symptoms become obvious; however, it is not presented as a substitute for veterinary diagnosis.
The company says an 18-month beta collected around 5 million data points from more than 80 dogs, identifying patterns later linked to an infected chipped tooth and tick fever. Hoomanely has shipped roughly 50 devices and charges $29 a month, but has not yet published independent measures of accuracy, sensitivity or false-positive rates. It plans formal veterinary studies and additional products, including a movement-tracking wearable called EverSense.
- AI feeding bowl seeks earlier warning of canine health problems.
- Evidence is limited so far, with no independent accuracy results.
- Hoomanely charges $29 monthly and plans veterinary studies.
New here? Start with this
Pet owners usually judge a dog’s health by visible symptoms or changes in behaviour, but some problems may be hard to spot early. Eating and drinking patterns can offer clues, though changes can have many causes and do not by themselves establish a diagnosis.
Hoomanely is a startup developing connected devices and software to collect information about dogs’ daily habits and share it with owners and vets. Its approach reflects a wider effort to use sensors and data analysis in pet care, while veterinary professionals remain responsible for assessing illness and recommending treatment.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
A feeding station used every day could help owners and vets notice gradual changes that are easy to miss, potentially prompting earlier checks and treatment. If the platform gives useful context without replacing clinical judgement, its ongoing observations may add value to veterinary care, especially as the company tests it in formal studies.
The case against
Without independent evidence on accuracy and false alarms, owners and vets cannot yet tell how reliably the system distinguishes illness from ordinary variation. Monthly costs and alerts that cause unnecessary worry or follow-up could limit its usefulness, so claims of early detection should remain provisional until larger studies establish its performance.